CombinoNews
International Trajectory
Combino Pharm began its international expansion programme in 2001 through licence and supply agreements with pharmaceutical laboratories in the EU.
In 2007, Combino Pharm began an important campaign to promote its product portfolio worldwide, which has resulted in a client portfolio across all five continents.
Combino Pharm currently has more than 100 agreements signed with companies from 70 countries.
Combino Pharm has a fully integrated network, which allows it to offer the client a personalised product from the registration application, the active pharmaceutical ingredient (API), (synthesised at Medichem, the group's chemical company), the pharmaceutical product in bulk or the finished product, produced in the pharmaceutical plant in Malta.
With the objective of providing a tailor-made, flexible service to each of our partners, Combino Pharm also works in collaboration with duly certified external manufacturers, both in the supply of API and in the manufacture of other pharmaceutical products (lyophilised vials, injectable solutions, infusion bags, etc.).
History
- 2001
- The first licence and supply agreement is signed for oral products
- 2002
- The first licence and supply agreement is signed for injectable products
- 2003
- Launch of first internal development product for export
- 2006
- Obtaining the EU GMP and beginning commercial manufacturing in Malta for export
- 2009
- Expansion to Oceania and Africa
- 2010
- Expansion to the Middle East and the CIS
- 2011
- Expansion to Southeast Asia
- 2012
- Expansion to South America
Data
Dossiers submitted (cumulative)
MA s Granted (cumulative)
